We know the Edison Research report is paid for, but still good to see the SP lifted from $0.71 to $0.87 There's a few really interesting bits in here: http://regeneus.com.au/media/analyst_reports/Edison-RegeneusUpdate040918.pdf
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
